Paraguay's approach to biotechnology governance: a comprehensive guide.
Mercosur
biologics
genetically modified organisms
recombinant DNA
vaccines
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2024
2024
Historique:
received:
19
01
2024
accepted:
05
03
2024
medline:
11
4
2024
pubmed:
11
4
2024
entrez:
11
4
2024
Statut:
epublish
Résumé
This study analyzes Paraguay's biotechnology regulatory framework and its alignment with international standards amid biotechnological advancements. It also identifies areas of improvement for enhancing framework effectiveness. Through this work, we aim to provide a resource for policymakers, stakeholders, and researchers navigating Paraguay's biotechnology regulation.
Identifiants
pubmed: 38600947
doi: 10.3389/fbioe.2024.1373473
pii: 1373473
pmc: PMC11004369
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1373473Informations de copyright
Copyright © 2024 Benítez Candia, Ulke Mayans, Sotelo, Nara Pereira, Arrúa Alvarenga and Fernández Ríos.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.